Share on Pinterest AstraZeneca’s COVID-19 vaccine has not been authorized for use in the United States but is being widely used in Europe. Manuel Dorati/Anadolu Agency via Getty Images The European Union’s medicines regulator said unusual blood clotting should be listed as a “very rare” side effect of AstraZeneca’s vaccine — though it emphasized that the benefits still outweigh the risks. The European Union’s medicines regulator said April 7 that unusual blood clotting with low blood platelets should be listed as a “very rare” side effect of the COVID-19 vaccine developed by AstraZeneca. Medicines and Healthcare products Regulatory Agency (MHRA) is recommending that people under age 30 be offered an alternative COVID-19 vaccine. They looked for blood clotting events including a type of brain clot called a cerebral venous sinus thrombosis.
At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.